We studied nine individuals from five unrelated families with aI/46-50a hereditary elliptocytosis (HE) The erythrocyte membrane skeleton is a network of proteins on the inner surface of the red cell membrane that is responsible for maintaining the shape and deformability ofthe erythrocyte (1-3). The principal proteins ofthe erythrocyte membrane skeleton include spectrin, ankyrin, protein 4.1, and actin (4). The major component of the erythrocyte membrane skeleton, spectrin, is composed oftwo structurally homologous but nonidentical proteins, a-and f3-spectrin. a-and j3-Spectrin intertwine to form heterodimers, which in turn self-associate in a head-to-head configuration to form tetramers and larger oligomers (5). These higher order tetramers and oligomers of spectrin appear to be critical for erythrocyte membrane stability as well as erythrocyte shape and function. Hemolytic anemias due to qualitative and quantitative defects in the erythrocyte membrane skeleton proteins, including spectrin, are an important group ofhereditary anemias. Hereditary elliptocytosis (HE)' and hereditary pyropoikilocytosis (HPP) are two of these disorders (for reviews, see references 6-9). HE, characterized by the presence of elliptically shaped erythrocytes in the peripheral blood, is a clinically heterogeneous group of disorders ranging from the asymptomatic carrier state to severe, symptomatic hemolytic anemia. HPP, as originally described by Zarkowsky et al. (10), is an uncommon, severe hemolytic anemia characterized by abnormal erythrocyte sensitivity to heat and erythrocyte morphology reminiscent of that seen in patients after a thermal burn. HE and HPP share a number ofbiochemical and molecular defects, particularly abnormalities in a spectrin (1 1-13).
Introduction
We studied nine individuals from five unrelated families with aI/46-50a hereditary elliptocytosis (HE) or hereditary pyropoikilocytosis (HPP), including one of the original HHP probands first reported by Zarkowsky and colleagues (1975. Br. J. Haematol. 29:537-543 ). Biochemical analysis of erythrocyte membrane proteins from these patients revealed, as a common abnormality, the presence of the aI/46-50a peptide after limited tryptic digestion of spectrin. The polymerase chain reaction was utilized to study the structure of the DNA encoding the al domain of spectrin in the affected individuals. The DNA sequence of the a-spectrin gene encoding the region of the aspectrin chain surrounding the abnormal proteolytic cleavage site was normal. We identified a point mutation causing the replacement of a highly conserved leucine residue by proline at position 207 in the a-spectrin chain, a site 51 residues to the amino-terminal side of the abnormal proteolytic cleavage site. Analysis of the proposed triple helical model of spectrin repeats reveals that the mutation occurs in helix 2 at a position directly opposite the abnormal proteolytic cleavage site in helix 3, making this the first report of a mutation occurring in helix 2 of a repeat in the al domain of spectrin. These results add to the molecular heterogeneity of mutations associated with HE/ HPP and provide further support for the proposed triple helical model of spectrin. Disruption of this proposed a-helical structure by helix-breaking proline substitutions may result in a functionally defective spectrin chain. (J. Clin. Invest. 1992. 89:892-898.) Key words: DNA sequence * erythrocyte membrane skeleton. hemolytic anemia * polymerase chain reaction
The erythrocyte membrane skeleton is a network of proteins on the inner surface of the red cell membrane that is responsible for maintaining the shape and deformability ofthe erythrocyte (1) (2) (3) . The principal proteins ofthe erythrocyte membrane skeleton include spectrin, ankyrin, protein 4.1, and actin (4) . The major component of the erythrocyte membrane skeleton, spectrin, is composed oftwo structurally homologous but nonidentical proteins, a-and f3-spectrin. a-and j3-Spectrin intertwine to form heterodimers, which in turn self-associate in a head-to-head configuration to form tetramers and larger oligomers (5). These higher order tetramers and oligomers of spectrin appear to be critical for erythrocyte membrane stability as well as erythrocyte shape and function.
Hemolytic anemias due to qualitative and quantitative defects in the erythrocyte membrane skeleton proteins, including spectrin, are an important group ofhereditary anemias. Hereditary elliptocytosis (HE)' and hereditary pyropoikilocytosis (HPP) are two of these disorders (for reviews, see references [6] [7] [8] [9] . HE, characterized by the presence of elliptically shaped erythrocytes in the peripheral blood, is a clinically heterogeneous group of disorders ranging from the asymptomatic carrier state to severe, symptomatic hemolytic anemia. HPP, as originally described by Zarkowsky et al. (10) , is an uncommon, severe hemolytic anemia characterized by abnormal erythrocyte sensitivity to heat and erythrocyte morphology reminiscent of that seen in patients after a thermal burn. HE and HPP share a number ofbiochemical and molecular defects, particularly abnormalities in a spectrin (1 1-13) .
After limited digestion with trypsin and two-dimensional polyacrylamide gel electrophoresis, normal spectrin can be resolved into five a and four ,B proteolytically resistant domains (14, 15) . The amino terminus of a-spectrin, the al domain, interacts with the carboxy terminus of fl-spectrin, the 1I domain, to form the oligomer binding site for heterodimer self-association. Defects in the al domain have been identified in a subset of patients with HE and HPP that lead to structural and functional abnormalities in spectrin. In these patients, limited tryptic digestion of mutant spectrins has revealed abnormal or enhanced proteolytic cleavage of the 80-kD fragment ofthe al domain with the generation of fragments of 78, 74, 65-68, 61, 46-50a, 50b, and 43 kD (reviewed in references 6-9). In some cases, amino acid and DNA sequencing has identified mutations near the sites of abnormal or enhanced proteolytic cleavage (16) (17) (18) (19) (20) (21) (22) .
This study describes the characterization ofa common mutation found in nine individuals from five unrelated kindreds with aI/46-50a (also referred to as SpalI/"6-) HE or HPP including one of the HPP probands originally described by Zarkowsky et al. (10) . This mutation occurs at some distance from the abnormal proteolytic cleavage site. Analysis of the proposed triple helical model of spectrin repeats reveals that the mutation occurs in helix 2 in a position directly opposite the abnormal proteolytic cleavage site in helix 3, making this the first report of a mutation occurring on helix 2 of the al domain of spectrin.
Methods
Erythrocyte deformability and membrane stability. These studies were performed by using an ektacytometer. Whole-cell deformability was followed as a function of the osmolality of the suspending medium as previously described (23) . The membrane resistance to sheer-induced fiagmentation was measured as described (24) .
Erythrocyte membrane preparation and quantitation of spectrin content. Red cell membranes were prepared as described (21) . Membrane proteins were analyzed by electrophoresis in SDS-PAGE either with a 5-15% polyacrylamide gradient as described by Laemmli (25) or using a 3.5% polyacrylamide gradient as described by Fairbanks et al. (4) . To estimate spectrin/band-3 ratios, SDS polyacrylamide slab gels (4) were scanned after Coomassie Blue staining using a DU8 spectrophotometer (Beckman Instruments, Inc., Fullerton, CA) at 550 nm.
Study of spectrin dimer-tetramer equilibrium. Spectrin was extracted by incubating white ghosts overnight at 4VC in low ionic strength buffer (26) . The content of spectrin dimers and tetramers was determined by nondenaturing gel electrophoresis as described (27, 28) .
Limited trypic digestion ofspectrin. Limited tryptic digests ofspectrin were prepared as described (21) . Spectrin peptides were separated by SDS-PAGE in a 7-15% polyacrylamide gradient and by two-dimensional electrophoresis as described by O'Farrell (29) and modified by Speicher et al. (14) . One-dimensional SDS-PAGE gels of spectrin tryptic digests were scanned at 550 nm after Coomassie Blue staining.
Partial amino acid sequencing of SpaI/46-SOa-kD peptide. After separation by SDS-PAGE, tryptic peptides were transferred onto polyvinylidene difluoride membranes (Immobilon, Millipore Corp., Bedford, MA). After staining with Coomassie Blue, the band corresponding to the 46-50a-kD peptide was excised and destained. Microsequencing analysis was performed with a gas-phase sequencer (model 740A, Applied Biosystems, Foster City, CA) (30) .
Oligonucleotide synthesis and genomic DNA amplification. Synthetic oligonucleotides were synthesized using an automated synthesizer (Applied Biosystems, Inc., Foster City, CA) and purified by gel electrophoresis or OPC column chromatography (Applied Biosystems, Inc.). The sequences of the various primers are listed in Table I . Selected exons of the spectrin al domain were amplified by the polymerase chain reaction (PCR) (31) using an automated DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, CT), as previously described ( 18) .
Subcloning ofamplified DNA. The amplification products were either blunt-end ligated into HincII-digested pGEM4 plasmid DNA (Progema Corp., Madison, WI) using T4 DNA ligase (New England Biolabs, Beverly, MA) or digested with EcoRl or HindIII, depending on the enzyme site incorporated into the oligonucleotide primer, and ligated into an appropriately prepared pGEM7 plasmid vector (Promega Corp., Madison, WI). The plasmid vectors were transfected into competent DH5a E. coli.
Sequencing ofsubcloned genomic DNA. Subcloned genomic DNA fragments were sequenced by using T7 DNA polymerase (Sequenase, United States Biochemical Corp., Cleveland, OH) and the dideoxy chain termination method of Sanger et al. (32) .
Direct sequencing ofamplified DNA. PCR-amplified products were purified by agarose gel electrophoresis and one halfofthe amplification products were subjected to a second round of PCR. Conditions were identical to that described above except that primers were used in a 1:50 picomolar ratio and 40 cycles of amplification were completed (33) . Amplification products were passed through an Amicon 30 filter (W.R. Grace & Co., Danvers, MA) before nucleotide sequencing. Sequence analysis was carried out using, as sequencing primer, the primer present in limiting concentration (1 pmol) 
Results
Quantitation of spectrin content and study of spectrin dimertetramer equilibrium. (Fig. 1) . Digests from four asymptomatic, elliptocytic family members of patient 5 showed the presence of the 46-50a-kD peptide and decreased normal 80-kD peptide (. 50%) (Fig. 1) . One-and two-dimensional gels from patients 1 (35) , 2 (36) , and 3 (data not shown) revealed the presence ofthe mutant 46-50a-kD peptide as well as virtual absence of the normal 80-kD aI domain spectrin peptide. Gels from patient 4 showed the presence ofthe mutant 46-50a-kD peptide and decreased normal 80-kD peptide (not Sequence analysis of subcloned PCR-amplified DNA fragments encoding a spectrin exon 5 from patients 1 and 2 revealed a single nucleotide substitution at codon position 207 CGT (leucine) to CCG (proline) (Fig. 2 a) . This substitution was present in 10 of 10 subclones in patient 1 and in 3 of 12 subclones in patient 2. Direct sequencing of PCR-amplified exon 5 revealed heterozygosity for the same mutation in patients 3 (Fig. 2 b) and 4 and homozygosity for the mutation in patient 5. The affected amino acid residue (no. 207) of the a-spectrin chain is located in the second typical repeat of the a-spectrin chain at position 79 ofthe repeat (38) , near the middle of helix 2 in the proposed triple helical model of Speicher and Marchesi (39) . A number of point mutations due to proline substitutions have been identified in the spectrin from HE and HPP patients (16, 18, 37) . Proline residues have a high propensity to disrupt a helices thus underscoring the importance ofthe proposed a helical conformation in the structure of spectrin chains.
Direct nucleotide sequencing of exon 7 in patients 1 and 2 revealed a single nucleotide change at position 299, AGC to AGT, which does not change the encoded amino acid residue (serine). This change probably represents a silent polymorphism.
Restriction enzyme digestion and slot blot analysis. The authenticity of this mutation was confirmed by restriction enzyme digestion and allele specific oligomer hybridization of amplified DNA from separate PCR reactions. The nucleotide substitution at codon 207 creates an MspI restriction site, CCGG, facilitating detection of this mutation. Digestion of amplification products ofexon 5 with MspI cleaves the normal fragment of 289 bp into fragments of 183 and 106 bp. Analytical digestion shows homozygosity for this mutation in patients 1 and 5, heterozygosity in the seven other HE or HPP individuals, and no digestion in control subjects (Fig. 3) .
The presence of this nucleotide substitution was also confirmed by ASO hybridization. Patients 2, 3, and 4 had both the normal and mutant alleles whereas patients 1 ity (10) (11) (12) . Many of the same molecular defects found in the spectrin of HE patients have been identified in HPP patients, including defective dimer self-association and structural alterations of the aI domain of spectrin (1 1-13, 36). HE and HPP have been classified according to the type of structural abnormality of the aI domain of spectrin detected after limited tryptic digestion. The subgroup associated with an abnormal aI/46-50a-kD peptide is proving to be heterogeneous in its clinical and biochemical manifestations, as well as its molecular basis (16, 18, (35) (36) (37) 40) . Clinically, affected individuals may range from asymptomatic carriers with normal hematocrits to patients with severe anemia with hemolysis requiring blood transfusion. The severity of impairment of spectrin self-association, as evidenced by percentage of spectrin dimers in extracts, varies widely in this group ofpatients, ranging from normal to markedly increased (12) . At the molecular level, two proline substitutions, at codons 260 and 261, have been previously described in HE/HPP associated with the aI/ 46-50a-kD abnormality. The identification of the codon 207 mutation adds to the molecular heterogeneity of HE/HPP associated with the aI 46-50a-kD abnormality.
In contrast, HE/HPP associated with the aI/65-68-kD abnormality is homogeneous at the molecular level, with all previously described cases being due to a leucine insertion between residues 154 and 156 (17, 18, 37) . HE/HPP associated with the aI/74-kD abnormality has been found to be due to a number of different amino acid substitutions in a-spectrin ( 19, 20, 41, 42) , an amino acid substitution in fl-spectrin (43) , and a number of truncated f3-spectrin chains (44) (45) (46) (47) (48) (49) ).
It appears that the codon 207 proline substitution is a relatively common cause ofthe aI 46-50a-kD abnormality. Assuming that the parents of patients 1 and 5 are unrelated, then this mutation is present in seven different kindreds. All patients are of black African ancestry. To determine if there is a founder effect associated with this mutation, the status ofan XbaI polymorphism in the aI domain of spectrin (50) was examined in amplified genomic DNA. Patients 1 and 5, who are homozygous for the codon 207 mutation, are also homozygous for the presence of the XbaI site, whereas patients 2, 3, and 4 are heterozygous for the RFLP and the codon 207 mutation. This result suggests that the 207 proline substitution is linked to the presence of the XbaI polymorphism, and that there is a common origin (i.e., a founder effect) for this mutation.
Generation of abnormal peptides from the al domain after limited tryptic digestion and two-dimensional gel electrophoresis provides important clues to the site of the underlying spectrin defect. According to the model proposed by Speicher and Marchesi (39) , both a-and #-spectrin consist mainly of a repeating structure of 106 amino acid repeats that can be theoretically folded into triple helical units, as illustrated in Fig. 4 A. The triple helical repeats consist ofalternating hydrophilic and hydrophobic regions, forming a coiled-coil structure resistant to proteolysis. Mutations in the amino terminus of a-spectrin or the carboxy terminus of f3-spectrin, the regions involved in spectrin dimer self-association, appear to disrupt this coiledcoil structure ofspectrin repeats, impairing spectrin dimer selfassociation. In a number of cases, amino acid sequencing has identified amino acid substitutions or insertions within two to four amino acid residues from the abnormal proteolytic cleavage site but also as far as 29 residues (16) (17) (18) (19) (20) (21) (22) . The proline substitution at codon 207 is located 51 amino acid residues to the amino-terminal side of the abnormal proteolytic cleavage site near the middle of proposed helix 2 ofthe second typical triple helical unit ofa-spectrin. The cleavage site that gives rise to the aI/46-50a-kD fragment in our patients is located at codon 258 near the middle of helix 3 in this unit, opposite the proline substitution (Fig. 4 B) .
The importance of helix 3 of each spectrin repeat in maintaining the structural integrity over the whole length of the dimer has been emphasized (16, 19) . A number of mutations associated with HE and HPP have been identified in the region corresponding to the proposed helix 3 in different repeats ofthe al domain of spectrin (reviewed in reference 8). There have been no previous reports of mutations in the proposed helix 2 region of a-spectrin. The substitution in our patients may disrupt the local conformation ofhelix 2, disturbing the secondary structure within the helical unit and probably exposing helix 3 to enhanced proteolysis. Thus the triple helical model explains how this distant amino acid substitution may cause a conformational change and enhanced proteolytic cleavage at a considerable distance from the site of the mutation thereby giving rise to the aI/46-50a peptide.
This result also provides evidence that the triple helical conformation is important for maintaining the integrity ofspectrin chains and indicates that a disruption ofthe triple helical structure may result in a functionally defective spectrin chain. However, the severity ofthe functional defect appears to depend on which triple helix is affected. Mutations located in the peptide segments directly implicated in the spectrin dimer self-association site lead to complete inability to form mutated homotetramers (13, 43) . Conversely, mutations located in triple helices far from the self-association site confer only a reduced affinity to self-association, as observed in the homozygous cases reported here or, for example, in patients homozygous for the spectrin aI/68-kD variant (13, 52) . This long range effect could imply that these mutations reduce the strain involved in the stabilization of the normal spectrin dimer conformation.
The HPP phenotype has been associated with homozygosity for an a-spectrin structural variant (e.g., patients 1 and 5) (27, 51, 52) , as well as double heterozygosity for two different structural variants (36, 41, (53) (54) (55) . Other (43) to show the potential intrachain interaction between a spectrin helices. The helices are numbered as proposed by Speicher and Marchesi (39) . (B) The mutation at position 207 (shown by the X) in helix 2 of the second triple segment of a spectrin could disrupt the structure of helix 2, thereby exposing helix 3 in the same segment to abnormal tryptic digestion at the site designated by the triangle, thus generating the aI/46-50a-kD peptide.
tural variant of spectrin, but marked deficiency of a-spectrin production, as evidenced by virtual absence of the normal al 80-kD peptide on tryptic maps of spectrin. Patients 2, 3, and 4 have increased spectrin dimers compared to homozygous patients and markedly increased spectrin dimers compared with other asymptomatic heterozygous aI/46-50a patients (e.g., family members of patient 5). These observations have led to speculation that a second defect causing decreased production ofspectrin from the other allele is present in these patients (7, 8, 55) , leading to increased clinical severity and increased spectrin dimers in extracts. The precise nature of this thalassemia-like defect in spectrin production remains unknown, but is the subject of ongoing investigation.
